About Us

Kyle Cetrulo

Co-chair Patient Advocacy Advisory Board

Kyle Cetrulo is a patient advocate and works diligently to bring life changing technologies to patients in need.  Kyle has unparalleled expertise, strategic vision, and a track record of success with over 25 years of experience in the regenerative medicine and longevity industry.

As a serial entrepreneur, Kyle currently is currently wearing many hats.  Kyle is the Founder and CEO of MyGutly, the first personalized Fecal Transplant company in the United States.  https://mygutly.com/ Kyle is the COO of MitrixBio, a leading mitochondria transplant company.  www.mitrix.bio

Prior to his work with MyGutly and MitrixBio, Kyle served as the CEO of Auxocell Laboratories, Inc., a prominent biotech company. In 2008, he founded Auxocell and from its inception as an idea, he secured the initial investment, assembled a highly skilled team, and led the company to profitability.

In 2013, he founded the 501(c)3 nonprofit organization, International Perinatal Stem Cell Society, Inc., and successfully hosted the society's inaugural international forum in May 2014. He hosted the 10th International Anniversary Congress in May 2023, showcasing his continued commitment to advancing the field of cellular therapy.  Kyle's deep involvement in the field is further highlighted by his editorship of three editions of Perinatal Stem Cells.

Throughout his career, Kyle has cultivated strong relationships with world-renowned scientists and speakers, leveraging his extensive network to establish partnerships with corporate sponsors for funding nonprofit initiatives.

Kyle is the host of the podcast Dragon Longevity where Kyle interviews guests from his stem cell and longevity background.  https://www.youtube.com/@DragonLongevity